The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Is BPC 157 Banned? Oral vs. Injectable Forms Explained Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law FDA to weigh easing limits on unproven peptides New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then,